S 
Shanghai General Healthy Information and Technology Co 605186.SS · CNY
Health Care · Shanghai · 🇨🇳 China
20.24
-1.08%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥345.5m
FY2016FY2025
Net income
CN¥30.8m
FY2016FY2025
Free cash flow
CN¥72.3m
FY2016FY2025
Shareholders' equity
CN¥1.10bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥345.5m | CN¥318.3m | CN¥307.6m | CN¥322.4m | CN¥489.8m | CN¥286.8m | CN¥300.2m | CN¥256.5m | CN¥233.0m | CN¥205.1m |
| Gross profit | CN¥150.9m | CN¥124.5m | CN¥168.6m | CN¥192.1m | CN¥207.4m | CN¥171.3m | CN¥168.4m | CN¥148.5m | CN¥140.8m | CN¥126.0m |
| Research and development | CN¥21.7m | CN¥21.1m | CN¥23.4m | CN¥22.4m | CN¥23.2m | CN¥16.3m | CN¥17.8m | CN¥12.6m | CN¥12.2m | CN¥7.6m |
| Operating income | CN¥58.2m | CN¥37.3m | CN¥67.6m | CN¥132.1m | CN¥143.8m | CN¥123.6m | CN¥121.2m | CN¥104.5m | CN¥83.5m | CN¥57.9m |
| Net income | CN¥30.8m | CN¥32.5m | CN¥60.0m | CN¥115.7m | CN¥117.6m | CN¥95.7m | CN¥91.9m | CN¥74.6m | CN¥55.4m | CN¥17.6m |
| Diluted earnings per share | 0.18 | 0.23 | 0.45 | 0.85 | 0.86 | 0.94 | 0.90 | 0.44 | 0.32 | 0.10 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥1.50bn | CN¥1.47bn | CN¥1.32bn | CN¥1.20bn | CN¥1.13bn | CN¥997.4m | CN¥482.4m | CN¥355.4m | CN¥263.5m | CN¥256.7m |
| Cash and short-term investments | — | CN¥123.8m | CN¥267.8m | CN¥366.3m | CN¥468.9m | CN¥559.9m | CN¥148.6m | CN¥133.9m | CN¥102.5m | CN¥94.2m |
| Total liabilities | CN¥313.2m | CN¥305.4m | CN¥179.1m | CN¥115.6m | CN¥154.0m | CN¥119.8m | CN¥131.3m | CN¥99.8m | CN¥85.0m | CN¥97.0m |
| Debt | — | CN¥126.3m | CN¥50.0m | CN¥6.6m | CN¥4.3m | CN¥11.9m | CN¥42.6m | CN¥2.0m | — | — |
| Shareholders' equity | CN¥1.10bn | CN¥1.07bn | CN¥1.05bn | CN¥1.00bn | CN¥901.5m | CN¥813.1m | CN¥287.6m | CN¥195.7m | CN¥121.1m | CN¥117.3m |
| Shares outstanding | 171m | 141m | 134m | 136m | 138m | 102m | 102m | 171m | 171m | 171m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥96.7m | CN¥17.7m | −CN¥35.4m | −CN¥37.3m | CN¥53.8m | CN¥71.8m | CN¥76.0m | CN¥67.9m | CN¥57.0m | CN¥58.2m |
| Capital spending | −CN¥24.5m | −CN¥136.6m | −CN¥37.1m | −CN¥66.7m | −CN¥81.4m | −CN¥60.9m | −CN¥96.6m | −CN¥23.7m | −CN¥915,963 | −CN¥5.0m |
| Free cash flow | CN¥72.3m | −CN¥118.9m | −CN¥72.5m | −CN¥104.0m | −CN¥27.5m | CN¥10.9m | −CN¥20.5m | CN¥44.2m | CN¥56.1m | CN¥53.2m |
| Dividends paid | −CN¥4.0m | −CN¥16.4m | −CN¥13.0m | −CN¥12.2m | −CN¥29.2m | — | −CN¥9.9m | −CN¥16.5m | — | −CN¥19.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥108.8m | CN¥76.0m | CN¥75.0m | CN¥111.8m | CN¥81.6m | CN¥77.1m | CN¥123.1m | CN¥49.7m |
| Gross profit | CN¥43.2m | CN¥25.2m | CN¥43.8m | CN¥36.1m | CN¥42.3m | CN¥28.6m | CN¥12.5m | CN¥23.8m |
| Operating income | CN¥13.8m | −CN¥2.0m | CN¥22.2m | CN¥5.3m | −CN¥56,737 | CN¥3.8m | CN¥6.3m | −CN¥2.6m |
| Net income | CN¥3.7m | CN¥3.4m | CN¥22.3m | CN¥3.4m | CN¥1.6m | CN¥3.4m | CN¥469,174 | CN¥2.5m |
| Diluted earnings per share | 0.02 | 0.02 | 0.13 | 0.02 | 0.01 | 0.02 | 0.00 | 0.02 |
| Cash from operations | — | — | — | CN¥18.0m | CN¥4.0m | −CN¥28.0m | — | CN¥59.0m |
| Capital spending | — | −CN¥5.0m | −CN¥1.0m | — | — | −CN¥22.0m | −CN¥76.0m | −CN¥7.0m |
| Free cash flow | — | — | — | — | — | −CN¥50.0m | — | CN¥52.0m |
| Total assets | CN¥1.57bn | CN¥1.46bn | CN¥1.50bn | CN¥1.59bn | CN¥1.44bn | CN¥1.47bn | CN¥1.47bn | CN¥1.44bn |
| Cash and short-term investments | — | — | — | CN¥144.4m | CN¥89.7m | CN¥80.9m | CN¥123.8m | CN¥169.4m |
| Debt | CN¥45.5m | — | — | CN¥187.3m | CN¥144.3m | CN¥183.3m | CN¥126.3m | CN¥148.8m |
| Shareholders' equity | CN¥1.11bn | CN¥1.11bn | CN¥1.10bn | CN¥1.08bn | CN¥1.08bn | CN¥1.08bn | CN¥1.07bn | CN¥1.07bn |
Financial ratios
Data as of 27 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 43.7% | 39.1% | 54.8% | 59.6% | 42.3% | 59.7% | — |
| Operating margin | 10.3% | 12.5% | 22.4% | 41.0% | 29.4% | 43.1% | — |
| Net margin | 8.9% | 10.2% | 19.5% | 35.9% | 24.0% | 33.4% | — |
| Return on equity | 2.8% | 3.0% | 5.7% | 11.5% | 13.0% | 11.8% | — |
| Return on assets | 2.1% | 2.2% | 4.6% | 9.6% | 10.4% | 9.6% | — |
| Free cash flow yield | 3.1% | 4.7% | 0.1% | 0.9% | 4.2% | 5.6% | — |
| Revenue growth | 8.5% | 3.5% | -4.6% | -34.2% | 70.8% | -4.5% | — |
| Earnings growth | -5.3% | -45.8% | -48.1% | -1.6% | 22.9% | 4.2% | — |
| Current ratio | 2.45x | 2.48x | 4.36x | 7.33x | 5.61x | 7.02x | — |
| Debt to equity | — | 0.12x | 0.05x | 0.01x | — | — | 0.15x |
| Equity ratio | 73.6% | 73.1% | 79.9% | 83.8% | 79.8% | 81.5% | — |
| Interest coverage | 8.91x | 12.74x | 58.47x | 1711.29x | 696.13x | 536.32x | — |
| R&D as a share of sales | 6.3% | 6.6% | 7.6% | 7.0% | 4.7% | 5.7% | — |
| Buybacks as a share of market value | -21.2% | -5.4% | 1.8% | 0.8% | -34.8% | 0.4% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 2.3% | 3.8% | — |
| Operating income | -23.9% | -14.0% | — |
| Net income | -35.7% | -20.3% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 41.5% | 49.2% | 49.0% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Price to earnings | 109.3 | 87.4 | 93.3 | 35.5 | 42.4 | 30.0 |
| Price to sales | 9.7 | 8.9 | 18.2 | 12.7 | 10.2 | 10.0 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 23 Aug 2024.
| FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Paid in the year | 0.10 | 0.09 | 0.09 | 0.215 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.